TC
PFE icon

Trust Company’s Pfizer PFE Stock Holding History

Trust Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460K Sell
19,095
-38,147
-67% -$998K 0.04% 110
2026
Q1 		$1.61M Buy
57,242
+1,819
+3% +$48.4K 0.15% 63
2025
Q4 		$1.38M Buy
55,423
+5,029
+10% +$127K 0.13% 68
2025
Q3 		$1.28M Buy
50,394
+23,540
+88% +$581K 0.13% 57
2025
Q2 		$651K Buy
26,854
+22,385
+501% +$522K 0.07% 73
2025
Q1 		$113K Buy
4,469
+829
+23% +$21.7K 0.01% 168
2024
Q4 		$96.6K Buy
3,640
+200
+6% +$5.42K 0.01% 177
2024
Q3 		$99.6K Sell
3,440
-347
-9% -$10.1K 0.01% 164
2024
Q2 		$106K Sell
3,787
-345
-8% -$9.5K 0.01% 149
2024
Q1 		$115K Sell
4,132
-357
-8% -$9.91K 0.02% 145
2023
Q4 		$129K Sell
4,489
-8,129
-64% -$246K 0.02% 139
2023
Q3 		$419K Sell
12,618
-1,316
-9% -$46.5K 0.07% 89
2023
Q2 		$511K Buy
13,934
+1,721
+14% +$67K 0.08% 83
2023
Q1 		$498K Sell
12,213
-827
-6% -$35.7K 0.08% 89
2022
Q4 		$668K Buy
13,040
+5
+0% +$240 0.11% 77
2022
Q3 		$570K Sell
13,035
-2,483
-16% -$121K 0.12% 75
2022
Q2 		$814K Sell
15,518
-13,285
-46% -$677K 0.18% 60
2022
Q1 		$1.49M Buy
28,803
+15,124
+111% +$785K 0.29% 39
2021
Q4 		$808K Sell
13,679
-28
-0.2% -$1.39K 0.19% 64
2021
Q3 		$590K Sell
13,707
-11,531
-46% -$511K 0.15% 66
2021
Q2 		$988K Sell
25,238
-1,557
-6% -$60.5K 0.69% 47
2021
Q1 		$971K Buy
26,795
+20,487
+325% +$727K 0.7% 46
2020
Q4 		$232K Buy
6,308
+940
+18% +$34.5K 0.18% 100
2020
Q3 		$187K Buy
5,368
+1,535
+40% +$53.8K 0.16% 107
2020
Q2 		$119K Sell
3,833
-1,235
-24% -$42K 0.11% 117
2020
Q1 		$157K Sell
5,068
-985
-16% -$33.6K 0.17% 84
2019
Q4 		$225K Sell
6,053
-9,250
-60% -$329K 0.2% 84
2019
Q3 		$522K Sell
15,303
-179
-1% -$6.51K 0.49% 53
2019
Q2 		$636K Sell
15,482
-81,756
-84% -$3.25M 0.59% 50
2019
Q1 		$3.92M Sell
97,238
-10,753
-10% -$431K 2.28% 8
2018
Q4 		$4.47M Buy
107,991
+96,013
+802% +$3.99M 2.49% 15
2018
Q3 		$501K Sell
11,978
-201
-2% -$7.74K 0.23% 50
2018
Q2 		$419K Buy
12,179
+201
+2% +$6.87K 0.19% 57
2018
Q1 		$403K Hold
11,978
– – 0.15% 58
2017
Q4 		$412K Hold
11,978
– – 0.17% 50
2017
Q3 		$406K Sell
11,978
-363
-3% -$11.7K 0.22% 47
2017
Q2 		$393K Sell
12,341
-901
-7% -$28.4K 0.18% 66
2017
Q1 		$430K Hold
13,242
– – 0.2% 72
2016
Q4 		$408K Buy
13,242
+367
+3% +$11.2K 0.21% 75
2016
Q3 		$414K Sell
12,875
-947
-7% -$31.7K 0.18% 88
2016
Q2 		$462K Hold
13,822
– – 0.18% 78
2016
Q1 		$389K Sell
13,822
-415
-3% -$11.9K 0.18% 80
2015
Q4 		$436K Sell
14,237
-4,214
-23% -$133K 0.2% 70
2015
Q3 		$550K Sell
18,451
-4,234
-19% -$136K 0.31% 63
2015
Q2 		$722K Buy
22,685
+9,486
+72% +$309K 0.45% 67
2015
Q1 		$436K Buy
+13,199
New +$420K 0.28% 86

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Trust Company's PFE Position: Q2 2026 in Review

Trust Company reduced its Pfizer (PFE) stake by 67% in Q2 2026, selling an estimated $998K and leaving 19,095 shares worth $460K. The position accounts for 0.04% of the portfolio, ranked #110.

Trust Company first reported a position in PFE in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.47M in Q4 2018. 669 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Trust Company held 19,095 shares of Pfizer worth $460K as of Q2 2026.
  • Trust Company sold 38,147 Pfizer shares in Q2 2026, an estimated $998K.
  • Pfizer made up 0.04% of Trust Company's portfolio in Q2 2026, its #110 holding.
  • Trust Company first reported a position in Pfizer in Q1 2015 and has held it in 46 quarters since.
  • Trust Company's Pfizer position peaked at $4.47M in Q4 2018.
  • 669 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.